Progress in Development of Targeted Therapeutic Drugs for Acute Myeloid Leukemia / 肿瘤防治研究
Cancer Research on Prevention and Treatment
; (12): 413-421, 2023.
Artículo
en Chino
| WPRIM (Pacífico Occidental)
| ID: wpr-986736
Biblioteca responsable:
WPRO
ABSTRACT
Targeted therapeutic drugs for acute myeloid leukemia (AML) are showing immense development, thereby laying a solid foundation for the precise treatment of AML patients. The paper reviews four types of targeted drugs that have progressed rapidly for AML treatment (by targeting genes or signaling-pathway alterations, targeting apoptosis-related pathways, targeting cell-surface antigens, and targeting immune-related substances). We look forward to the future development directions of targeted drugs, providing references for hematologists and developers of new drugs for AML.
Texto completo:
Disponible
Base de datos:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Cancer Research on Prevention and Treatment
Año:
2023
Tipo del documento:
Artículo